Articles

  • 1 week ago | hoistmagazine.com | Vidya Sagar Maddela

    DGCrane, a crane manufacturer based in China, has successfully exported a 2.5-ton single girder overhead crane and a 0.5-ton jib crane to a glass production company in Serbia. The Serbian customer first contacted DGCrane in November 2024, and after six months of discussions, decided to purchase the cranes to aid in lifting glass. The 2.5-ton single girder overhead crane features a span of 9m and a lifting height of 6m.

  • 1 week ago | ingredients-insight.com | Vidya Sagar Maddela

    California-based FK+, founded by leaders from Flow Kana and a major US herbal tea brand, has launched a new line of wellness products across the US. The FK+ range includes four formulations, FOCUS+, ENERGY+, RELAX+, and SLEEP+. The products combine cannabinoids, adaptogens, and nootropics to address stress, enhance mental and physical performance, and improve sleep quality.

  • 1 week ago | financedirectoreurope.com | Vidya Sagar Maddela

    UK-based insurance company Aviva has implemented the Reltio Data Cloud to enhance customer experiences through real-time data intelligence. Through the cloud-native platform, Aviva aims to unify its data, overcome previous challenges of data fragmentation and provide a complete view of customer interactions. Previously, Aviva’s legacy systems used separate master data management solutions for operational and marketing purposes, which complicated obtaining a holistic customer view.

  • 1 week ago | practical-patient-care.com | Vidya Sagar Maddela

    Harbor Regional Health in Aberdeen, Washington, has selected the Meditech Expanse electronic health record (EHR) system to modernise its care delivery. The implementation of the EHR system is part of a 33-year partnership with Meditech. The partnership aims to enhance patient experience and streamline clinician workflows through the cloud-based Meditech-as-a-Service (MaaS) subscription model.

  • 1 week ago | worldpharmaceuticals.net | Vidya Sagar Maddela

    Alvotech and Advanz Pharma have expanded their strategic partnership to include three additional biosimilar candidates for the European market. The agreement builds on their existing partnership, which focuses on enhancing their biosimilar portfolio in Europe. The expanded collaboration covers biosimilars to Ilaris (canakinumab), Kesimpta (ofatumumab), and an undisclosed early-stage candidate.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →